Article ID Journal Published Year Pages File Type
9311829 Urology 2005 5 Pages PDF
Abstract
Co-administration of intranasal PT-141 and a phosphodiesterase type 5 inhibitor may constitute a treatment alternative for patients in whom higher doses of a single therapy are not effective or well tolerated.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , ,